US Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER on Dec. 6 for "Methods and compositions for treating cancer using peptide nucleic acid-based agents" (New York, Connecticut Inventors)

  • Gary Schwartz

Press/Media

Period7 Dec 2022

Media coverage

1

Media coverage

  • TitleUS Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER on Dec. 6 for "Methods and compositions for treating cancer using peptide nucleic acid-based agents" (New York, Connecticut Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date7/12/22
    PersonsGary Schwartz
View all 1
View less